Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for lipoprotein(a) [Lp(a)], a largely overlooked genetic marker for cardiovascular risk, could significantly enhance early detection of heart disease and reduce long-term healthcare costs.

Aug. 18, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons, has identified early hemodynamic valve deterioration (HVD) in more than 6% of patients just one year after undergoing transcatheter aortic valve implantation (TAVI), raising new questions about valve durability in younger, lower-risk populations.

Aug. 18, 2025 — iRhythm Technologies, Inc. has announced the publication of a real-world evidence study: Assessment of Variation in AmbuLatory Cardiac MONitoring: Real-World Evidence of Commercially Insured Beneficiaries (AVALON) in the American Journal of Managed Care reinforcing the clinical performance of the Zio long-term continuous monitoring (LTCM) service.

Aug. 19, 2025 — In a move to advance stroke care and accelerate critical decision-making, Tift Regional Medical Center (TRMC) has implemented RapidAI’s deep clinical AI platform, bringing faster insights and improved coordination to stroke response teams. The technology is now live across TRMC’s stroke program and is already helping clinicians deliver more timely and informed care.

Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they have successfully completed the clinical study evaluating a machine learning-based algorithm for non-invasively identifying patients with elevated pulmonary capillary wedge pressure (PCWP) – a key indicator of both heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).

Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company announced its financial and operational results for the quarter ending June 30, 2025.

Among the 2025 operational highlights, the company reported it continues to make significant progress toward commercial readiness, along with key clinical and regulatory achievements on the HeartBeam System.

12-Lead ECG Synthesis Software FDA Submission:

Aug. 13, 2025 — BioCardia, Inc., a provider of cellular and cell-derived therapeutics for treating cardiovascular and pulmonary diseases, and CART-Tech, B.V., a provider of vendor independent platform technology for augmented fluoroscopy during cardiac interventions, have announced they have entered into an exclusive development and commercialization agreement for Heart3D Fusion Imaging.

Aug. 14, 2025 — Philips has announced a plan for new investments of more than $150 million in U.S. manufacturing and research and development (R&D).  Philips also unveiled the expansion of its Reedsville, PA, manufacturing facility, which produces AI-enabled ultrasound systems for hospitals across the U.S.

August 14, 2025 — PaceMate has officially completed a year-long project, resulting in two new exclusive abilities. The company can now directly migrate all historical patient data from PaceArt Optima to PaceMateLIVE. It is the only company to integrate with SessionSync, the in-clinic data capture tool for Medtronic devices, and wirelessly transfer in-clinic patient data.

Aug. 7, 2025 — Gentuity LLC, a medical technology company specializing in next-generation intravascular imaging devices, has announced an agreement with GE HealthCare to collaborate on commercial activities. The collaboration is intended to enhance the availability, adoption and functionality of highly complementary imaging solutions for interventional cardiology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now